Global Cystic Fibrosis (CF) Therapeutics Market Size, Status and Forecast 2020-2026

May 2020 | 98 pages | ID: G96B6FD7954FEN
QYResearch

Abstracts

This report focuses on the global Cystic Fibrosis (CF) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cystic Fibrosis (CF) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Vertex Pharmaceuticalsorporated
• Gilead
• AbbVie,
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Alaxia
• Merck & Co.
• AIT (Advanced Inhalation Therapies)
• ALLERGAN
• AstraZeneca
• Teva Pharmaceutical Industries Ltd
• Alcresta

Market segment by Type, the product can be split into

• Pancreatic enzyme supplements
• Mucolytics
• Bronchodilators
• CFTR modulators

Market segment by Application, split into

• Oral drugs
• Inhaled drugs

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cystic Fibrosis (CF) Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Cystic Fibrosis (CF) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cystic Fibrosis (CF) Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cystic Fibrosis (CF) Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Pancreatic enzyme supplements
  1.4.3 Mucolytics
  1.4.4 Bronchodilators
  1.4.5 CFTR modulators
1.5 Market by Application
  1.5.1 Global Cystic Fibrosis (CF) Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Oral drugs
  1.5.3 Inhaled drugs
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cystic Fibrosis (CF) Therapeutics Market Perspective (2015-2026)
2.2 Cystic Fibrosis (CF) Therapeutics Growth Trends by Regions
  2.2.1 Cystic Fibrosis (CF) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cystic Fibrosis (CF) Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cystic Fibrosis (CF) Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Cystic Fibrosis (CF) Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Market Size
  3.1.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cystic Fibrosis (CF) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio
  3.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis (CF) Therapeutics Revenue in 2019
3.3 Cystic Fibrosis (CF) Therapeutics Key Players Head office and Area Served
3.4 Key Players Cystic Fibrosis (CF) Therapeutics Product Solution and Service
3.5 Date of Enter into Cystic Fibrosis (CF) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2021-2026)

5 CYSTIC FIBROSIS (CF) THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020)
5.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cystic Fibrosis (CF) Therapeutics Market Size (2015-2020)
6.2 Cystic Fibrosis (CF) Therapeutics Key Players in North America (2019-2020)
6.3 North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020)
6.4 North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size (2015-2020)
7.2 Cystic Fibrosis (CF) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Cystic Fibrosis (CF) Therapeutics Market Size (2015-2020)
8.2 Cystic Fibrosis (CF) Therapeutics Key Players in China (2019-2020)
8.3 China Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020)
8.4 China Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cystic Fibrosis (CF) Therapeutics Market Size (2015-2020)
9.2 Cystic Fibrosis (CF) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size (2015-2020)
10.2 Cystic Fibrosis (CF) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Cystic Fibrosis (CF) Therapeutics Market Size (2015-2020)
11.2 Cystic Fibrosis (CF) Therapeutics Key Players in India (2019-2020)
11.3 India Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020)
11.4 India Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cystic Fibrosis (CF) Therapeutics Market Size (2015-2020)
12.2 Cystic Fibrosis (CF) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Vertex Pharmaceuticalsorporated
  13.1.1 Vertex Pharmaceuticalsorporated Company Details
  13.1.2 Vertex Pharmaceuticalsorporated Business Overview and Its Total Revenue
  13.1.3 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Introduction
  13.1.4 Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020))
  13.1.5 Vertex Pharmaceuticalsorporated Recent Development
13.2 Gilead
  13.2.1 Gilead Company Details
  13.2.2 Gilead Business Overview and Its Total Revenue
  13.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Introduction
  13.2.4 Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  13.2.5 Gilead Recent Development
13.3 AbbVie,
  13.3.1 AbbVie, Company Details
  13.3.2 AbbVie, Business Overview and Its Total Revenue
  13.3.3 AbbVie, Cystic Fibrosis (CF) Therapeutics Introduction
  13.3.4 AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  13.3.5 AbbVie, Recent Development
13.4 Novartis AG
  13.4.1 Novartis AG Company Details
  13.4.2 Novartis AG Business Overview and Its Total Revenue
  13.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Introduction
  13.4.4 Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  13.4.5 Novartis AG Recent Development
13.5 F. Hoffmann-La Roche Ltd
  13.5.1 F. Hoffmann-La Roche Ltd Company Details
  13.5.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
  13.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Introduction
  13.5.4 F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  13.5.5 F. Hoffmann-La Roche Ltd Recent Development
13.6 Alaxia
  13.6.1 Alaxia Company Details
  13.6.2 Alaxia Business Overview and Its Total Revenue
  13.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Introduction
  13.6.4 Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  13.6.5 Alaxia Recent Development
13.7 Merck & Co.
  13.7.1 Merck & Co. Company Details
  13.7.2 Merck & Co. Business Overview and Its Total Revenue
  13.7.3 Merck & Co. Cystic Fibrosis (CF) Therapeutics Introduction
  13.7.4 Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  13.7.5 Merck & Co. Recent Development
13.8 AIT (Advanced Inhalation Therapies)
  13.8.1 AIT (Advanced Inhalation Therapies) Company Details
  13.8.2 AIT (Advanced Inhalation Therapies) Business Overview and Its Total Revenue
  13.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Introduction
  13.8.4 AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  13.8.5 AIT (Advanced Inhalation Therapies) Recent Development
13.9 ALLERGAN
  13.9.1 ALLERGAN Company Details
  13.9.2 ALLERGAN Business Overview and Its Total Revenue
  13.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Introduction
  13.9.4 ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  13.9.5 ALLERGAN Recent Development
13.10 AstraZeneca
  13.10.1 AstraZeneca Company Details
  13.10.2 AstraZeneca Business Overview and Its Total Revenue
  13.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Introduction
  13.10.4 AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  13.10.5 AstraZeneca Recent Development
13.11 Teva Pharmaceutical Industries Ltd
  10.11.1 Teva Pharmaceutical Industries Ltd Company Details
  10.11.2 Teva Pharmaceutical Industries Ltd Business Overview and Its Total Revenue
  10.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Introduction
  10.11.4 Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  10.11.5 Teva Pharmaceutical Industries Ltd Recent Development
13.12 Alcresta
  10.12.1 Alcresta Company Details
  10.12.2 Alcresta Business Overview and Its Total Revenue
  10.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Introduction
  10.12.4 Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
  10.12.5 Alcresta Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cystic Fibrosis (CF) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Cystic Fibrosis (CF) Therapeutics Revenue
Table 3. Ranking of Global Top Cystic Fibrosis (CF) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pancreatic enzyme supplements
Table 6. Key Players of Mucolytics
Table 7. Key Players of Bronchodilators
Table 8. Key Players of CFTR modulators
Table 9. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cystic Fibrosis (CF) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cystic Fibrosis (CF) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cystic Fibrosis (CF) Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cystic Fibrosis (CF) Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Cystic Fibrosis (CF) Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Cystic Fibrosis (CF) Therapeutics Players
Table 20. Global Cystic Fibrosis (CF) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2019)
Table 23. Global Cystic Fibrosis (CF) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cystic Fibrosis (CF) Therapeutics Product Solution and Service
Table 26. Date of Enter into Cystic Fibrosis (CF) Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Cystic Fibrosis (CF) Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Cystic Fibrosis (CF) Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Cystic Fibrosis (CF) Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Cystic Fibrosis (CF) Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Cystic Fibrosis (CF) Therapeutics Market Share (2019-2020)
Table 36. North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Cystic Fibrosis (CF) Therapeutics Market Share by Type (2015-2020)
Table 38. North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Cystic Fibrosis (CF) Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Cystic Fibrosis (CF) Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Cystic Fibrosis (CF) Therapeutics Market Share (2019-2020)
Table 42. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Cystic Fibrosis (CF) Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Cystic Fibrosis (CF) Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Cystic Fibrosis (CF) Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Cystic Fibrosis (CF) Therapeutics Market Share (2019-2020)
Table 48. China Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Cystic Fibrosis (CF) Therapeutics Market Share by Type (2015-2020)
Table 50. China Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Cystic Fibrosis (CF) Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Cystic Fibrosis (CF) Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Cystic Fibrosis (CF) Therapeutics Market Share (2019-2020)
Table 54. Japan Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Cystic Fibrosis (CF) Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Cystic Fibrosis (CF) Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Cystic Fibrosis (CF) Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Cystic Fibrosis (CF) Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Cystic Fibrosis (CF) Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Cystic Fibrosis (CF) Therapeutics Market Share (2019-2020)
Table 66. India Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Cystic Fibrosis (CF) Therapeutics Market Share by Type (2015-2020)
Table 68. India Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Cystic Fibrosis (CF) Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Cystic Fibrosis (CF) Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Cystic Fibrosis (CF) Therapeutics Market Share (2019-2020)
Table 72. Central & South America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Cystic Fibrosis (CF) Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Cystic Fibrosis (CF) Therapeutics Market Share by Application (2015-2020)
Table 76. Vertex Pharmaceuticalsorporated Company Details
Table 77. Vertex Pharmaceuticalsorporated Business Overview
Table 78. Vertex Pharmaceuticalsorporated Product
Table 79. Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 80. Vertex Pharmaceuticalsorporated Recent Development
Table 81. Gilead Company Details
Table 82. Gilead Business Overview
Table 83. Gilead Product
Table 84. Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 85. Gilead Recent Development
Table 86. AbbVie, Company Details
Table 87. AbbVie, Business Overview
Table 88. AbbVie, Product
Table 89. AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 90. AbbVie, Recent Development
Table 91. Novartis AG Company Details
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Product
Table 94. Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 95. Novartis AG Recent Development
Table 96. F. Hoffmann-La Roche Ltd Company Details
Table 97. F. Hoffmann-La Roche Ltd Business Overview
Table 98. F. Hoffmann-La Roche Ltd Product
Table 99. F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 100. F. Hoffmann-La Roche Ltd Recent Development
Table 101. Alaxia Company Details
Table 102. Alaxia Business Overview
Table 103. Alaxia Product
Table 104. Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 105. Alaxia Recent Development
Table 106. Merck & Co. Company Details
Table 107. Merck & Co. Business Overview
Table 108. Merck & Co. Product
Table 109. Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 110. Merck & Co. Recent Development
Table 111. AIT (Advanced Inhalation Therapies) Business Overview
Table 112. AIT (Advanced Inhalation Therapies) Product
Table 113. AIT (Advanced Inhalation Therapies) Company Details
Table 114. AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 115. AIT (Advanced Inhalation Therapies) Recent Development
Table 116. ALLERGAN Company Details
Table 117. ALLERGAN Business Overview
Table 118. ALLERGAN Product
Table 119. ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 120. ALLERGAN Recent Development
Table 121. AstraZeneca Company Details
Table 122. AstraZeneca Business Overview
Table 123. AstraZeneca Product
Table 124. AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 125. AstraZeneca Recent Development
Table 126. Teva Pharmaceutical Industries Ltd Company Details
Table 127. Teva Pharmaceutical Industries Ltd Business Overview
Table 128. Teva Pharmaceutical Industries Ltd Product
Table 129. Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 130. Teva Pharmaceutical Industries Ltd Recent Development
Table 131. Alcresta Company Details
Table 132. Alcresta Business Overview
Table 133. Alcresta Product
Table 134. Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2015-2020) (Million US$)
Table 135. Alcresta Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cystic Fibrosis (CF) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Pancreatic enzyme supplements Features
Figure 3. Mucolytics Features
Figure 4. Bronchodilators Features
Figure 5. CFTR modulators Features
Figure 6. Global Cystic Fibrosis (CF) Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Oral drugs Case Studies
Figure 8. Inhaled drugs Case Studies
Figure 9. Cystic Fibrosis (CF) Therapeutics Report Years Considered
Figure 10. Global Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Cystic Fibrosis (CF) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Cystic Fibrosis (CF) Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players in 2019
Figure 15. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue in 2019
Figure 17. North America Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Vertex Pharmaceuticalsorporated Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Vertex Pharmaceuticalsorporated Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 26. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Gilead Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 28. AbbVie, Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. AbbVie, Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 30. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis AG Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 32. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 34. Alaxia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Alaxia Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 36. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Merck & Co. Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 38. AIT (Advanced Inhalation Therapies) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. AIT (Advanced Inhalation Therapies) Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 40. ALLERGAN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. ALLERGAN Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 42. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. AstraZeneca Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 44. Teva Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 46. Alcresta Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Alcresta Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed